Abstract
Introduction
Lymphomas are a heterogeneous group of immune-cell malignancies. Immunology-related conditions are among the few factors for which consistent evidence exists relating them to lymphoma risk.
Materials and methods
We used the data from the European case–control study Epilymph on 2,362 lymphoma cases and 2,458 controls to investigate associations between a medical history of infectious and non-infectious diseases with overall and subentity-specific lymphoma risk.
Results
As key results, we observed an increased odds ratio (OR) for self-reported infections with hepatitis B virus (HBV, OR = 1.91, 95% CL = 1.24–2.94) and a null result for rheumatoid arthritis. Additionally, we found an increased OR for infectious mononucleosis (OR = 1.68, 95% CL = 1.14–2.48), an inverse association to frequency of sickness in childhood (OR = 0.68, 95% CL = 0.55–0.84), and—as casual finding—an increased OR with acetaminophen intake (OR = 2.29, 95% CL = 1.49–3.51).
Conclusion
Our results are consistent with the current knowledge about the association with mononucleosis as indicator of Epstein–Barr-virus infection, suggest serological study of the association to HBV infection and do not support the view of a positive association between rheumatoid arthritis and lymphoma risk.
Similar content being viewed by others
References
Alexander DD, Mink PJ, Adamit H-O, Chang ET, Cole P, Mandel JS, Trichopoulos D (2007) The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 120:1–39. doi:10.1002/ijc.22719
Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI, Ricker W, Parsons R, Wheeler W, Engels EA (2008) Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev 17(11):3069–3075. doi:10.1158/1055-9965.EPI-08-0408
Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L (1998) Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case–control study. Br Med J 317:180–181
Baris D, Zahm SH (2000) Epidemiology of lymphomas. Curr Opin Oncol 12:383–394. doi:10.1097/00001622-200009000-00002
Becker N, Deeg E, Nieters A (2004) Population-based study of lymphomas in Germany: rationale, study design and first results. Leuk Res 28:713–724. doi:10.1016/j.leukres.2003.11.010
Becker N, Deeg E, Rüdiger T, Nieters A (2005) Medical history and risk for lymphoma: results of a population-based case–control study in Germany. Eur J Cancer 41:133–142. doi:10.1016/j.ejca.2004.08.028
Becker N, de Sanjosé S, Nieters A, Maynadié M, Foretova L, Cocco PL, Staines A, Alvaro T, Vornanen M, Brennan P, Boffetta P (2007) Birth order, allergies and lymphoma risk: results of the European collaborative research project Epilymph. Leuk Res 31:1365–1372. doi:10.1016/j.leukres.2007.02.019
Besson H, Brennan P, Becker N, Nieters A, de Sanjosé S, Font R, Maynadié M, Foretova L, Cocco PL, Staines A, Vornanen M, Boffetta P (2006) Tobacco smoking, alcohol drinking and non-Hodgkin lymphoma: a European multicenter case–control study (Epilymph). Int J Cancer 119:901–908. doi:10.1002/ijc.21913
Boffetta P, Armstrong B, Linet M, Kasten C, Cozen W, Hartge P (2007) Consortia in cancer epidemiology: lessons from the Interlymph. Cancer Epidemiol Biomarkers Prev 16:197–199. doi:10.1158/1055-9965.EPI-06-0786
Cartwright R, Brincker H, Carli PM, Clayden D, Coebergh JW, Jack A, McNally R, Morgan G, de Sanjose S, Tumino R, Vornanen M (1999) The rise in incidence of lymphomas in Europe 1985–1992. Eur J Cancer 35:627–633. doi:10.1016/S0959-8049(98)00401-8
Cocco P, Piras G, Monne M, Uras A, Gabbas A, Ennas MG, Palmas A, Murineddu M, Collu S, Melis M, Rais M, Todde P, Cabras MG, Angelucci E, Massarelli G, Nieters A (2008) Risk of malignant lymphoma following viral hepatitis infection. Int J Hematol 87:474–483. doi:10.1007/s12185-008-0086-3
Devesa SS, Fears T (1992) Non-Hodgkin’s lymphoma time trends: United States and International Data. Cancer Res 52:5432s–5440s
Ekström Smedby K, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, Sundström C, Akerman M, Melbye M, Glimelius B, Adami H-O (2006) Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98:51–60
Ekström Smedby K, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjosé S, Chiu BC-H, Dal Maso L, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111:4029–4038. doi:10.1182/blood-2007-10-119974
Fortuny J, Benavente Y, Bosch R, García-Villanueva M, de Sevilla AF, de Sanjosé S (2005) Type 2 diabetes mellitus, its treatment and risk for lymphoma. Eur J Cancer 41:1782–1787. doi:10.1016/j.ejca.2005.04.032
Fortuny J, de Sanjosé S, Becker N, Maynadié M, Cocco PL, Staines A, Foretovea L, Vornanen M, Brennan P, Nieters A, Alvaro T, Boffetta P (2006) Statin use and risk of lymphoid neoplasms: results from the European case–control study EPILYMPH. Cancer Epidemiol Biomarkers Prev 15(5):921–925. doi:10.1158/1055-9965.EPI-05-0866
Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami H-O, Hacker DG, Hoover R, Fraumeni JF Jr (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85:307–311. doi:10.1093/jnci/85.4.307
Holford TR, Zheng T, Mayne ST, McKay LA (1992) Time trends of non-Hodgkin’s lymphoma: are they real? what do they mean? Cancer Res 52:5443s–5446s
Howe HL, Wingo PA, Thun MJ, Ries LAG, Rosenberg HM, Feigal EG, Edwards BK (2001) Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93:824–842. doi:10.1093/jnci/93.11.824
Jaffé ESHN, Stein H, Vardiman JW (eds) (2001) Pathology and genetics of tumours of hematopoietic and lymphoid tissues. IARC Press, Lyon (France)
Kim LH, Bang Y-J, Park BJ, Yoo T, Kim CW, Kim T-Y, Heo DS, Lee H-S, Kim NK (2002) Hepatitis B virus infection and B-cell non-Hodgkin lymphoma in a hepatitis B endemic area: a case–control study. Jpn J Cancer Res 93:471–477
Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K, Fukutomi M, Yokota M, Nishi H, Iwamoto H, Uike N, Nishimura J, Inaba S, Maeda Y, Nawata H, Muta K (2001) Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin’s lymphoma. J Gastroenterol Hepatol 16:215–219. doi:10.1046/j.1440-1746.2001.02406.x
La Vecchia C, Negri E, Franceschi S, d’Avanzo B, Boyle P (2004) A case–control study of diabetes mellitus and cancer risk. Br J Cancer 70:950–953
Marcucci F, Mele A, Spada E, Candidi A, Bianco E, Pulsioni A, Chionne P, Madonna E, Cotichini R, Barbui A, de Renzo A, Dore F, Iannitto E, Liso V, Martino B, Montanaro M, Pagano L, Musto P, Rapicetta M (2006) High prevalence of hepatitis B virus infection in B-cell non-Hodgkin’s lymphoma. Haematologica 91:554–557
Martinez-Gamboa L, Brezinschek H-P, Burmester GR, Dörner T (2006) Immunopathologic role of B lymphocoytes in rheumatoid arthritis: rationale of B cell-directed therapy. Autoimmun Rev 5:437–442. doi:10.1016/j.autrev.2006.02.004
Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH (1996) Rheumatoid arthritis and cancer risk. Eur J Cancer 32A(10):1753–1757. doi:10.1016/0959-8049(96)00210-9
Moysich KB, Bonner MR, Beehler GP, Marshall JR, Menezes RJ, Baker JA, Weiss JR, Chanan-Khan A (2007) Regular analgesics use and risk of multiple myeloma. Leuk Res 31:547–551. doi:10.1016/j.leukres.2006.07.027
Nieters A, Kallinowski B, Brennan P, Ott M, Maynadié M, Benavente Y, Foretova L, Cocco PL, Staines A, Vornanen M, Whitby D, Boffetta P, Becker N, de Sanjosé S (2006) Hepatitis C and risk of lymphoma: results of the european multicenter case–control study EPILYMPH. Gastroenterology 131:1879–1886. doi:10.1053/j.gastro.2006.09.019
RC IA (1997) Epstein–Barr virus and Kaposi’s sarcoma Herpesvirus/Human Herpesvirus 8. IARC monographs on the evaluation of carcinogenic risks to humans, vol vol 70. IARC Press, Lyon
Shaffer AL, Rosenwald A, Staudt LM (2002) Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol 2:920–932. doi:10.1038/nri953
Talamini R, Montella M, Crovatto M, dal Maso L, Crispo A, Negri E, Spina M, Pinto A, Carbone A, Franceschi S (2004) Non-Hodgkin’s lymphoma and hepatitis C virus: a case–control study from northern and southern Italy. Int J Cancer 110:380–385. doi:10.1002/ijc.20137
Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94:252–266
Ulcickas YM, Quesenberry CB, Guo D, Caldwell G, Wells K, Shan J, Sanders L, Skovron ML, Iloeje U, Manos MM (2007) Incidence of non-Hodgkin’s lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 46:107–112. doi:10.1002/hep.21642
Wang F, Xu R, Han B, Shi Y, Luo H, Jiang W, Lin T, Huang H, Xia Z, Guan Z (2007) High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer 109:1360–1364. doi:10.1002/cncr.22549
Weiss JR, Baker JA, Bare MR, Menezes RJ, Nowell S, Moysich KB (2006) Opposing effects of aspirin and acetaminophen use on risk of adult acute leukaemia. Leuk Res 30:164–169. doi:10.1016/j.leukres.2005.06.023
Young LS, Rickinson AB (2004) Epstein–Barr virus: 40 years on. Nat Rev Cancer 4:757–768. doi:10.1038/nrc1452
Acknowledgments
We are indebted to Aurélie Meunier (IARC, Lyon) and Evelin Deeg (German Cancer Research Center, Heidelberg) who performed data management (A.M. and E.D.) and assisted data analysis (E.D.). This work was supported by: the EC 5th Framework Program Quality of Life grant No. QLK4-CT-2000-00422; La Fondation de France, no. 1999 0084 71 (France); the Federal Office for Radiation Protection grants No. StSch4261 and StSch4420 (Germany); the Health Research Board, Ireland; the Spanish Ministry of Health grants FIS: 04-0091 and CIBERESP (Spain).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Becker, N., Fortuny, J., Alvaro, T. et al. Medical history and risk of lymphoma: results of a European case–control study (EPILYMPH). J Cancer Res Clin Oncol 135, 1099–1107 (2009). https://doi.org/10.1007/s00432-009-0551-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-009-0551-2